Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1003369 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-TAR (HIV-1) RNA Binding Protein 2 (TARBP2) (Internal Region) antibody
- Antibody type
- Polyclonal
- Antigen
- TRBP1 antibody was raised in rabbits against a 17 amino acid peptide from near the center of human TRBP1.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µg
- Storage
- -20°C Shipping Temperature: 4°C
- Handling
- Antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. During shipment, small volumes of antibody will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 myl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap.
Submitted references Identification of a group of cellular cofactors that stimulate the binding of RNA polymerase II and TRP-185 to human immunodeficiency virus 1 TAR RNA.
The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA.
Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR.
Wu-Baer F, Lane WS, Gaynor RB
The Journal of biological chemistry 1996 Feb 23;271(8):4201-8
The Journal of biological chemistry 1996 Feb 23;271(8):4201-8
The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA.
Wu-Baer F, Lane WS, Gaynor RB
The EMBO journal 1995 Dec 1;14(23):5995-6009
The EMBO journal 1995 Dec 1;14(23):5995-6009
Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR.
Gatignol A, Buckler-White A, Berkhout B, Jeang KT
Science (New York, N.Y.) 1991 Mar 29;251(5001):1597-600
Science (New York, N.Y.) 1991 Mar 29;251(5001):1597-600
No comments: Submit comment
No validations: Submit validation data